Fluorine in PDB 6xvg: Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801
Enzymatic activity of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801
All present enzymatic activity of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801:
2.3.1.286;
Protein crystallography data
The structure of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801, PDB code: 6xvg
was solved by
W.You,
C.Steegborn,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
46.39 /
2.10
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
89.510,
136.534,
89.873,
90.00,
117.71,
90.00
|
R / Rfree (%)
|
20.4 /
23
|
Other elements in 6xvg:
The structure of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801 also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801
(pdb code 6xvg). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801, PDB code: 6xvg:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 6xvg
Go back to
Fluorine Binding Sites List in 6xvg
Fluorine binding site 1 out
of 6 in the Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F404
b:80.6
occ:1.00
|
F1
|
A:8L9404
|
0.0
|
80.6
|
1.0
|
C39
|
A:8L9404
|
1.4
|
82.2
|
1.0
|
C38
|
A:8L9404
|
2.4
|
74.2
|
1.0
|
C40
|
A:8L9404
|
2.4
|
87.8
|
1.0
|
BR1
|
A:8L9404
|
3.1
|
82.6
|
1.0
|
CG2
|
A:VAL115
|
3.3
|
39.9
|
1.0
|
CZ
|
A:PHE64
|
3.4
|
47.0
|
1.0
|
C36
|
A:8L9404
|
3.6
|
82.1
|
1.0
|
C42
|
A:8L9404
|
3.6
|
89.0
|
1.0
|
CE2
|
A:PHE64
|
3.9
|
44.7
|
1.0
|
C35
|
A:8L9404
|
4.1
|
84.2
|
1.0
|
CL1
|
A:8L9404
|
4.2
|
76.2
|
1.0
|
CE1
|
A:PHE64
|
4.5
|
47.6
|
1.0
|
CB
|
A:VAL115
|
4.7
|
37.8
|
1.0
|
CZ
|
A:PHE86
|
4.8
|
46.5
|
1.0
|
C43
|
A:8L9404
|
4.9
|
85.7
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 6xvg
Go back to
Fluorine Binding Sites List in 6xvg
Fluorine binding site 2 out
of 6 in the Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F404
b:0.5
occ:1.00
|
F1
|
B:8L9404
|
0.0
|
0.5
|
1.0
|
C39
|
B:8L9404
|
1.4
|
0.7
|
1.0
|
C38
|
B:8L9404
|
2.3
|
98.7
|
1.0
|
C40
|
B:8L9404
|
2.4
|
96.1
|
1.0
|
BR1
|
B:8L9404
|
3.0
|
0.1
|
1.0
|
CG2
|
B:VAL115
|
3.0
|
43.4
|
1.0
|
C36
|
B:8L9404
|
3.6
|
0.3
|
1.0
|
CZ
|
B:PHE64
|
3.6
|
46.1
|
1.0
|
C42
|
B:8L9404
|
3.7
|
98.0
|
1.0
|
CL1
|
B:8L9404
|
3.9
|
0.3
|
1.0
|
O
|
B:HOH530
|
4.0
|
46.6
|
1.0
|
C35
|
B:8L9404
|
4.1
|
0.8
|
1.0
|
CE2
|
B:PHE64
|
4.2
|
46.9
|
1.0
|
CB
|
B:VAL115
|
4.5
|
40.9
|
1.0
|
CE1
|
B:PHE64
|
4.6
|
47.3
|
1.0
|
CZ
|
B:PHE86
|
4.8
|
49.5
|
1.0
|
C43
|
B:8L9404
|
5.0
|
97.8
|
1.0
|
CG1
|
B:VAL115
|
5.0
|
44.7
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 6xvg
Go back to
Fluorine Binding Sites List in 6xvg
Fluorine binding site 3 out
of 6 in the Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F1006
b:95.8
occ:1.00
|
F1
|
C:8L91006
|
0.0
|
95.8
|
1.0
|
C39
|
C:8L91006
|
1.4
|
84.9
|
1.0
|
C38
|
C:8L91006
|
2.3
|
80.5
|
1.0
|
C40
|
C:8L91006
|
2.4
|
94.8
|
1.0
|
BR1
|
C:8L91006
|
3.0
|
82.5
|
1.0
|
CZ
|
C:PHE64
|
3.0
|
56.0
|
1.0
|
CG2
|
C:VAL115
|
3.2
|
42.1
|
1.0
|
CE2
|
C:PHE64
|
3.6
|
54.1
|
1.0
|
C36
|
C:8L91006
|
3.6
|
78.8
|
1.0
|
C42
|
C:8L91006
|
3.7
|
96.4
|
1.0
|
CE1
|
C:PHE64
|
4.1
|
56.9
|
1.0
|
C35
|
C:8L91006
|
4.1
|
94.1
|
1.0
|
CB
|
C:VAL115
|
4.6
|
43.0
|
1.0
|
N
|
C:VAL115
|
4.8
|
35.1
|
1.0
|
C43
|
C:8L91006
|
4.9
|
92.8
|
1.0
|
CD2
|
C:PHE64
|
4.9
|
53.9
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 6xvg
Go back to
Fluorine Binding Sites List in 6xvg
Fluorine binding site 4 out
of 6 in the Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F404
b:89.2
occ:1.00
|
F1
|
D:8L9404
|
0.0
|
89.2
|
1.0
|
C39
|
D:8L9404
|
1.4
|
95.1
|
1.0
|
C38
|
D:8L9404
|
2.4
|
83.4
|
1.0
|
C40
|
D:8L9404
|
2.4
|
93.6
|
1.0
|
CG2
|
D:VAL115
|
3.1
|
40.0
|
1.0
|
BR1
|
D:8L9404
|
3.2
|
84.9
|
1.0
|
C36
|
D:8L9404
|
3.7
|
84.7
|
1.0
|
C42
|
D:8L9404
|
3.7
|
89.1
|
1.0
|
CZ
|
D:PHE64
|
3.7
|
52.3
|
1.0
|
C35
|
D:8L9404
|
4.2
|
90.4
|
1.0
|
CE2
|
D:PHE64
|
4.2
|
54.9
|
1.0
|
CB
|
D:VAL115
|
4.5
|
44.4
|
1.0
|
CZ
|
D:PHE86
|
4.5
|
59.8
|
1.0
|
CE1
|
D:PHE86
|
4.7
|
60.6
|
1.0
|
CE1
|
D:PHE64
|
4.7
|
52.0
|
1.0
|
CL1
|
D:8L9404
|
4.7
|
88.6
|
1.0
|
N
|
D:VAL115
|
4.8
|
38.0
|
1.0
|
C43
|
D:8L9404
|
5.0
|
82.0
|
1.0
|
N
|
D:ASP116
|
5.0
|
33.0
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 6xvg
Go back to
Fluorine Binding Sites List in 6xvg
Fluorine binding site 5 out
of 6 in the Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F705
b:90.3
occ:1.00
|
F1
|
E:8L9705
|
0.0
|
90.3
|
1.0
|
C39
|
E:8L9705
|
1.4
|
92.5
|
1.0
|
C38
|
E:8L9705
|
2.4
|
85.8
|
1.0
|
C40
|
E:8L9705
|
2.4
|
89.1
|
1.0
|
BR1
|
E:8L9705
|
3.0
|
93.9
|
1.0
|
CG2
|
E:VAL115
|
3.3
|
50.8
|
1.0
|
C42
|
E:8L9705
|
3.6
|
90.0
|
1.0
|
C36
|
E:8L9705
|
3.6
|
81.4
|
1.0
|
CZ
|
E:PHE86
|
3.7
|
56.1
|
1.0
|
CE1
|
E:PHE86
|
3.8
|
56.1
|
1.0
|
C35
|
E:8L9705
|
4.1
|
95.9
|
1.0
|
CZ
|
E:PHE64
|
4.2
|
56.5
|
1.0
|
O
|
E:HOH821
|
4.4
|
53.4
|
1.0
|
N
|
E:ASP116
|
4.6
|
42.4
|
1.0
|
CG2
|
E:ILE61
|
4.7
|
52.2
|
1.0
|
CB
|
E:VAL115
|
4.7
|
51.4
|
1.0
|
CE1
|
E:PHE64
|
4.8
|
55.5
|
1.0
|
C43
|
E:8L9705
|
4.8
|
90.8
|
1.0
|
C
|
E:VAL115
|
4.9
|
45.4
|
1.0
|
CA
|
E:ASP116
|
4.9
|
43.9
|
1.0
|
CB
|
E:ASP116
|
4.9
|
42.7
|
1.0
|
N
|
E:VAL115
|
5.0
|
45.9
|
1.0
|
CE2
|
E:PHE86
|
5.0
|
58.7
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 6xvg
Go back to
Fluorine Binding Sites List in 6xvg
Fluorine binding site 6 out
of 6 in the Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human SIRT6 3-318 in Complex with Adp-Ribose and the Activator Mdl-801 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:F403
b:99.2
occ:1.00
|
F1
|
F:8L9403
|
0.0
|
99.2
|
1.0
|
C39
|
F:8L9403
|
1.4
|
0.6
|
1.0
|
C38
|
F:8L9403
|
2.4
|
0.5
|
1.0
|
C40
|
F:8L9403
|
2.4
|
0.4
|
1.0
|
BR1
|
F:8L9403
|
3.1
|
0.8
|
1.0
|
CG2
|
F:VAL115
|
3.4
|
51.0
|
1.0
|
C36
|
F:8L9403
|
3.6
|
0.1
|
1.0
|
C42
|
F:8L9403
|
3.7
|
0.1
|
1.0
|
CZ
|
F:PHE64
|
3.7
|
70.5
|
1.0
|
CE2
|
F:PHE64
|
4.0
|
67.8
|
1.0
|
C35
|
F:8L9403
|
4.1
|
0.3
|
1.0
|
CE1
|
F:PHE64
|
4.7
|
73.2
|
1.0
|
CZ
|
F:PHE86
|
4.8
|
59.1
|
1.0
|
CB
|
F:VAL115
|
4.8
|
55.3
|
1.0
|
N
|
F:VAL115
|
4.9
|
50.8
|
1.0
|
C43
|
F:8L9403
|
4.9
|
0.8
|
1.0
|
CE1
|
F:PHE86
|
4.9
|
61.8
|
1.0
|
|
Reference:
W.You,
C.Steegborn.
Crystal Structures of SIRT6 Complexes with the Allosteric Activator Mdl-801 Reveal Binding Site and Interaction Details To Be Published.
Page generated: Fri Aug 2 04:18:13 2024
|